tiprankstipranks
RenovoRx (RNXT)
NASDAQ:RNXT
US Market

RenovoRx (RNXT) Income Statement

50 Followers

RenovoRx Income Statement

Last quarter (Q3 2023), RenovoRx's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, RenovoRx's net income was $-1.42M. See RenovoRx’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19
Total Revenue
---$ 0.00$ 0.00
Cost of Revenue
-----
Gross Profit
-----
Operating Expense
$ 927.00K$ 9.95M$ 5.67M$ 3.20M$ 3.90M
Operating Income
$ -5.27M$ -9.95M$ -5.67M$ -3.20M$ -3.90M
Net Non Operating Interest Income Expense
$ 112.00K$ 57.00K$ -834.00K$ -587.00K$ 63.00K
Other Income Expense
$ -2.53M$ -4.00K$ -181.00K$ -7.00K$ -6.00K
Pretax Income
$ -2.64M$ -9.89M$ -6.32M$ -3.80M$ -3.84M
Tax Provision
$ 922.00K$ -922.00K$ 331.00K--
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -2.64M$ -9.89M$ -6.32M$ -3.80M$ -3.84M
Basic EPS
$ -0.94$ -1.09$ -1.21$ -0.45$ -0.46
Diluted EPS
$ -0.71$ -1.09$ -1.21$ -0.45$ -0.46
Basic Average Shares
$ 39.49M$ 9.05M$ 5.22M$ 8.38M$ 8.38M
Diluted Average Shares
$ 30.44M$ 9.05M$ 5.22M$ 8.38M$ 8.38M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 927.00K$ 9.95M$ 5.67M$ 3.20M$ 3.90M
Net Income From Continuing And Discontinued Operation
$ -9.16M$ -9.89M$ -6.32M$ -3.80M$ -3.84M
Normalized Income
$ -2.96M--$ -3.80M$ -3.83M
Interest Expense
---$ 590.00K$ 0.00
EBIT
$ -2.65M$ -9.89M$ -5.49M$ -3.20M$ -3.84M
EBITDA
$ -2.65M$ -9.88M$ -4.78M$ -3.20M$ -3.84M
Currency in USD

RenovoRx Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis